CRIS Current Research Information System

BUONTEMPO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.912
AS - Asia 2.277
EU - Europa 1.784
AF - Africa 167
Continente sconosciuto - Info sul continente non disponibili 144
SA - Sud America 102
OC - Oceania 3
Totale 7.389
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.878
SG - Singapore 644
VN - Vietnam 634
CN - Cina 532
GB - Regno Unito 432
IT - Italia 318
SE - Svezia 269
DE - Germania 228
HK - Hong Kong 139
FR - Francia 114
IN - India 100
RU - Federazione Russa 93
ZA - Sudafrica 74
IE - Irlanda 68
BR - Brasile 59
UA - Ucraina 48
JP - Giappone 43
TG - Togo 38
EE - Estonia 34
JO - Giordania 33
NL - Olanda 32
BD - Bangladesh 28
CH - Svizzera 22
FI - Finlandia 22
CI - Costa d'Avorio 21
KR - Corea 21
AT - Austria 20
IR - Iran 20
AR - Argentina 17
BG - Bulgaria 17
CA - Canada 17
BE - Belgio 15
PL - Polonia 13
SC - Seychelles 12
CL - Cile 11
TR - Turchia 10
PH - Filippine 9
PK - Pakistan 9
SA - Arabia Saudita 9
TH - Thailandia 9
ID - Indonesia 8
ES - Italia 7
CO - Colombia 6
NG - Nigeria 6
RO - Romania 6
CZ - Repubblica Ceca 5
MX - Messico 5
PT - Portogallo 5
UZ - Uzbekistan 5
EC - Ecuador 4
JM - Giamaica 4
LB - Libano 4
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
IQ - Iraq 3
MA - Marocco 3
TW - Taiwan 3
VE - Venezuela 3
AU - Australia 2
BY - Bielorussia 2
LT - Lituania 2
MY - Malesia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
CR - Costa Rica 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GI - Gibilterra 1
GM - Gambi 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MQ - Martinica 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 7.243
Salva come PNG Salva come JPEG
Città #
Singapore 455
Southend 375
Ashburn 336
Fairfield 267
Chandler 180
Dong Ket 173
Houston 169
Woodbridge 151
Bologna 141
Wilmington 138
Hong Kong 132
San Jose 132
Seattle 127
Santa Clara 121
Ann Arbor 105
Ho Chi Minh City 104
Cambridge 88
Princeton 79
Hanoi 74
Dublin 68
Beijing 67
Boardman 56
Dallas 52
New York 49
Hefei 45
Los Angeles 43
Lauterbourg 41
Nanjing 40
Westminster 40
Lomé 38
Padova 35
Amman 33
Johannesburg 31
Tokyo 29
Frankfurt am Main 27
Berlin 23
Abidjan 21
Bremen 21
Jinan 21
Shenyang 21
Bern 20
Changsha 20
Jacksonville 19
Council Bluffs 18
Helsinki 18
Saint Petersburg 18
Redondo Beach 17
Sofia 17
Buffalo 15
Seoul 15
Brussels 14
Nanchang 14
Turin 14
Vienna 14
Da Nang 13
Falls Church 13
Guangzhou 13
Haiphong 12
Rome 12
The Dalles 12
Florence 11
Hangzhou 11
Medford 11
Zhengzhou 11
Chicago 10
Haikou 10
London 10
Norwalk 10
Redmond 10
San Diego 10
Shanghai 10
Hebei 9
San Francisco 9
São Paulo 9
Tianjin 9
Orem 8
Toronto 8
Amsterdam 7
Atlanta 7
Dearborn 7
Munich 7
Mülheim 7
Nuremberg 7
Pune 7
Abeokuta 6
Falkenstein 6
Fuzhou 6
Jiaxing 6
Ningbo 6
Warsaw 6
Washington 6
Bengaluru 5
Biên Hòa 5
Hải Dương 5
Ninh Bình 5
Parma 5
Phoenix 5
Redwood City 5
Andover 4
Ankara 4
Totale 4.756
Salva come PNG Salva come JPEG
Nome #
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 266
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 262
Dosimetric analysis and experimental setup design for in-vivo irradiation with a Plasma Focus device 246
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device 241
Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line 224
Therapeutic targeting of CK2 in acute and chronic leukemias. 223
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 221
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 216
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 213
Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells. 211
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 208
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 205
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 201
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a 199
Drug discovery targeting the mTOR pathway 195
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 194
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 193
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 181
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 179
Compact and very high dose-rate plasma focus radiation sources for medical applications 173
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 173
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 172
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 171
Protective effect of different antioxidant agents in UVB-irradiated keratinocytes 165
Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. 165
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 164
Nuclear phosphoinositides and their roles in cell biology and disease. 161
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 161
Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications 158
Marine bisindole alkaloid: a potential apoptotic inducer in cancer cells. 152
Diet modulation restores autophagic flux in damaged skeletal muscle cells. 151
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 137
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 136
GSK-3β: a key regulator of breast cancer drug resistance 134
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. 125
EVALUATION OF THE EFFICACY AND ANTITUMOR ACTIVITY OF THE PAN-CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITOR NVP-BKM120 IN HUMAN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) 114
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells 113
Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status 113
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 103
INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY? 99
null 95
HNE protein adducts and apoptosis in osteosarcoma cells 72
Tyrosol prevents apoptosis in irradiated keratinocytes. 61
null 43
Totale 7.389
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.667
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022799 0 19 61 59 78 48 19 61 33 126 180 115
2022/2023855 78 119 48 131 55 61 29 42 166 9 71 46
2023/2024261 18 34 25 25 26 89 5 9 7 11 7 5
2024/2025801 15 111 81 63 177 42 56 27 1 58 33 137
2025/20262.169 183 149 190 124 250 155 257 120 436 180 80 45
2026/202760 53 7 0 0 0 0 0 0 0 0 0 0
Totale 7.389